Abstract：
BACKGROUND:Distal symmetric polyneuropathy (DSPN) is the most common complication of type 2 diabetes mellitus (T2DM) and the most common form of peripheral neuropathy. DSPN increases the risk of foot ulceration up to seven-fold, and is a significant risk factor in more than 60 % of the amputations of the lower limbs in patients with T2DM. The aims of our study were to evaluate the difference in the density of intraepidermal nerve fibers (IENF) in patients with respectively without DSPN, to evaluate the strength of the relationship between the symptomatology of the DSPN and IENF density and to define a cutoff value of the IENF density for the diagnosis of DSPN. METHODS:We enrolled, according to a consecutive, population-based method, 36 patients with T2DM admitted in our Clinic. For all patients, we measured HbA1c, lipid profile, body mass index and we assessed the presence and severity of DSPN using the evaluation of clinical symptoms, nerve conduction velocity and IENF density quantification. RESULTS:The presence of neuropathy was significantly associated with a decreased density of IENF for both the proximal (11.6 vs. 14.9 fibers/mm; p = 0.014) and the distal biopsies (7.2 vs. 8.6 fibers/mm; p = 0.020). The optimal threshold value of IENF density (the point with the maximum sum of specificity and sensitivity), according to our model, was 10.1 fibers/mm. CONCLUSIONS:Skin biopsy followed by IENF density quantification is a valid, reliable tool for the diagnosis of DSPN.
journal_name
Diabetol Metab Syndrjournal_title
Diabetology & metabolic syndromeauthors
Timar B,Popescu S,Timar R,Baderca F,Duica B,Vlad M,Levai C,Balinisteanu B,Simu Mdoi
10.1186/s13098-016-0146-4subject
Has Abstractpub_date
2016-04-11 00:00:00pages
31issn
1758-5996pii
146journal_volume
8pub_type
杂志文章abstract：Background:Type 2 diabetes is a chronic disease associated with poorer health outcomes and decreased health related quality of life (HRQoL). The aim of this analysis was to explore the impact of a disease management programme (DMP) in type 2 diabetes on HRQoL. A multilevel model was used to explain the variation in EQ-...
journal_title：Diabetology & metabolic syndrome
pub_type： 杂志文章
doi：10.1186/s13098-018-0330-9
更新日期：2018-04-10 00:00:00
abstract：BACKGROUND:Patients with either diabetes mellitus (DM) or metabolic syndrome (MS) are recognized as a high risk group for cardiovascular disease (CVD). Several studies have demonstrated the clinical value of MS for predicting additional CVD risk in the DM population, although the clinical significance remains debatable...
journal_title：Diabetology & metabolic syndrome
pub_type： 杂志文章
doi：10.1186/1758-5996-6-98
更新日期：2014-09-12 00:00:00
abstract：Background:Previous studies comparing insulin degludec/insulin aspart (IDegAsp) with premixed insulin twice daily among insulin users with type 2 diabetes have not thoroughly investigated differences in the glucose variability and psychological evaluations related to insulin regimen changes. We investigated changes in ...
journal_title：Diabetology & metabolic syndrome
pub_type： 杂志文章
doi：10.1186/s13098-018-0366-x
更新日期：2018-08-16 00:00:00
abstract：BACKGROUND:Dietary factors are important environmental factors associated with the prevalence of metabolic syndrome (MS). The objective of this study was to assess the habitual nutrient intakes of patients with MS. METHODS:A cross-sectional study included 103 patients (82 % women) with MS seen at the endocrinology out...
journal_title：Diabetology & metabolic syndrome
pub_type： 杂志文章
doi：10.1186/s13098-016-0147-3
更新日期：2016-04-14 00:00:00
abstract：BACKGROUND:The aim of this study is to compare the efficacy of intensification of insulin treatment with insulin glargine and biphasic human insulin in patients with type 2 diabetes on concomitant therapy with oral antidiabetic drugs (OAD) in daily clinical practice. METHODS:A retrospective multicentre parallel two-ar...
journal_title：Diabetology & metabolic syndrome
pub_type： 杂志文章
doi：10.1186/1758-5996-5-43
更新日期：2013-08-05 00:00:00
abstract：BACKGROUND:Coronary artery disease (CAD) is a major cardiovascular complication in diabetic patients. Despite the significant association between obesity and diabetes, the majority of the diabetic subjects are not obese in an Asian population. This study evaluated the association between obesity and coronary artery dis...
journal_title：Diabetology & metabolic syndrome
pub_type： 杂志文章
doi：10.1186/1758-5996-6-134
更新日期：2014-12-05 00:00:00
abstract：Purpose:People with obesity have a compromised browning capacity of adipose tissue when faced with sympathetic stimuli. This study aimed to determine whether norepinephrine treatment can enhance the induction of precursor cells from human white adipose tissue to differentiate into adipocytes that express key markers of...
journal_title：Diabetology & metabolic syndrome
pub_type： 杂志文章
doi：10.1186/s13098-020-00599-z
更新日期：2020-10-22 00:00:00
abstract：BACKGROUND:Type 2 diabetes and its management affect the patient and the close family potentially causing either psychological distress or increased sense of responsibility and collaboration in these families. Interactions between patient and family play an important role in maintaining lifestyle changes and diabetes s...
journal_title：Diabetology & metabolic syndrome
pub_type： 杂志文章,评审
doi：10.1186/s13098-017-0256-7
更新日期：2017-07-21 00:00:00
abstract：BACKGROUND:Hypertriglyceridemia (HTG) is considered an independent risk factor for major adverse cardiovascular events (MACE). METHODS:This study analyzed the effects of various agents on MACE risk reduction in HTG (serum triglyceride ≥ 150 mg/dl) populations by performing a network meta-analysis. We performed a frequ...
journal_title：Diabetology & metabolic syndrome
pub_type： 杂志文章
doi：10.1186/s13098-021-00626-7
更新日期：2021-01-29 00:00:00
abstract：BACKGROUND:The oral DPP-4 inhibitors are new incretin-based therapies for treatment of type 2 diabetes. To assess the efficacy and safety of three DPP-4 inhibitors (Saxagliptin, Sitagliptin and Vildagliptin) as add-on therapy to dual combination of traditional oral hypoglycemic agents in Chinese type 2 diabetes patient...
journal_title：Diabetology & metabolic syndrome
pub_type： 杂志文章
doi：10.1186/1758-5996-6-69
更新日期：2014-05-31 00:00:00
abstract：Background:The role of serum fibroblast growth factor 19 (FGF19) in arteriosclerosis is not well known. In the present study, we aimed to explore whether serum FGF19 levels were related to arteriosclerosis parameters, including arterial stiffness and atherogenic index of plasma (AIP), in patients with type 2 diabetes (...
journal_title：Diabetology & metabolic syndrome
pub_type： 杂志文章
doi：10.1186/s13098-020-00552-0
更新日期：2020-05-20 00:00:00
abstract：OBJECTIVE:The primary purpose of this study was to examine the construct validity of a continuous metabolic syndrome score (cMetS) in children. The secondary purpose was to identify a cutpoint value(s) for an adverse cMetS based on receiver operating characteristic (ROC) curve analysis. METHODS:378 children aged 7 to ...
journal_title：Diabetology & metabolic syndrome
pub_type： 杂志文章
doi：10.1186/1758-5996-2-8
更新日期：2010-01-28 00:00:00
abstract：Background:Several studies suggest that statin may increase the risk of new-onset diabetes mellitus (NODM). This study aimed to evaluate the association between the duration and recent use of statin, and the risk of NODM, based on population-based data sets. Methods:We used the South Korean National Health Insurance S...
journal_title：Diabetology & metabolic syndrome
pub_type： 杂志文章
doi：10.1186/s13098-019-0427-9
更新日期：2019-04-22 00:00:00
abstract：UNLABELLED: BACKGROUND:Achieving good glycemic control is of paramount importance in the reduction of diabetes mellitus (DM) associated morbidity and mortality. Insulin plays a key role in the management of DM but unfortunately whilst some healthcare providers present insulin as a treatment of last resort , patients o...
journal_title：Diabetology & metabolic syndrome
pub_type： 杂志文章
doi：10.1186/1758-5996-4-50
更新日期：2012-12-02 00:00:00
abstract：OBJECTIVE:To study the clinical and molecular characteristics of a sample of Brazilian patients with Congenital Hyperinsulinemic Hypoglycemia (CHH). METHODS:Electronic message was sent to members from Endocrinology Department- Brazilian Society of Pediatrics requesting clinical data for all cases of CHH. A whole blood...
journal_title：Diabetology & metabolic syndrome
pub_type： 杂志文章
doi：10.1186/1758-5996-7-5
更新日期：2015-02-18 00:00:00
abstract：OBJECTIVE:To translate and validate the instrument Diabetes Self-Management Profile (DSMP)-Conventional and Flexible Regimens into Brazilian Portuguese language in order to evaluate the quality of diabetes self-management in children and adolescents with type 1 diabetes and their caregivers. METHODS:DSMP was submitted...
journal_title：Diabetology & metabolic syndrome
pub_type： 杂志文章
doi：10.1186/s13098-017-0250-0
更新日期：2017-07-11 00:00:00
abstract：BACKGROUND:Liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, has been shown to possess pleiotropic effects including body weight reduction. However, long-term effect of liraglutide on body weight and glycemic control has not been elucidated in Japanese type 2 diabetes (T2D) subjects. Present study investigates w...
journal_title：Diabetology & metabolic syndrome
pub_type： 杂志文章
doi：10.1186/1758-5996-6-95
更新日期：2014-09-08 00:00:00
abstract：Background:To investigate the association of low carbohydrate diet (LCD) score with the risk of type 2 diabetes among adults. Methods:This cohort study was conducted on 4356 healthy participants aged ≥ 19 years old, who were followed-up for a mean duration of 3 years within the framework of the Tehran Lipid and Glucos...
journal_title：Diabetology & metabolic syndrome
pub_type： 杂志文章
doi：10.1186/s13098-020-00596-2
更新日期：2020-10-07 00:00:00
abstract：Background:Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in patients with type 2 diabetes (T2DM). Carotid intima-media thickness (CIMT) is considered a preclinical stage of atherosclerosis. Therefore, it is necessary to identify the related risk factors for CIMT to facilitate the early pr...
journal_title：Diabetology & metabolic syndrome
pub_type： 杂志文章
doi：10.1186/s13098-020-0517-8
更新日期：2020-01-28 00:00:00
abstract：Background:Endothelial dysfunction (ED) is a hallmark in type 2 diabetes mellitus (T2DM) that favor both atherogenesis and ischemia and reperfusion injury (IRI). Sodium-glucose-2 co-transporter inhibitors (SGLT2i) may hypothetically improve microvascular and macrovascular functions via a broad spectrum of mechanisms, b...
journal_title：Diabetology & metabolic syndrome
pub_type： 杂志文章
doi：10.1186/s13098-019-0457-3
更新日期：2019-07-31 00:00:00
abstract：BACKGROUND:Non-alcoholic steatohepatitis (NASH) is highly associated with metabolic syndrome, a major cause of morbidity in the globalized society. The renin-angiotensin system (RAS) influences hepatic fatty acid metabolism, inflammation and fibrosis. Thus, in the present study, we aimed to evaluate the effect of alisk...
journal_title：Diabetology & metabolic syndrome
pub_type： 杂志文章
doi：10.1186/s13098-017-0282-5
更新日期：2017-10-13 00:00:00
abstract：BACKGROUND:Polymorphisms of vitamin D receptor (VDR) gene have been studied as genetic markers of type 1 diabetes mellitus (T1DM) and some studies have reported associations with autoimmune thyroid disease. The aim of this study was to evaluate the relationship between VDR FokI polymorphism (rs10735810), thyroid autoim...
journal_title：Diabetology & metabolic syndrome
pub_type： 杂志文章
doi：10.1186/s13098-016-0145-5
更新日期：2016-03-22 00:00:00
abstract：UNLABELLED: BACKGROUND:Plant flavonoids are emerging as potent therapeutic drugs effective against a wide range of aging diseases particularly bone metabolic disorders. Morin (3,5,7,20,40-pentahydroxyflavone), a member of flavonols, is an important bioactive compound by interacting with nucleic acids, enzymes and prot...
journal_title：Diabetology & metabolic syndrome
pub_type： 杂志文章
doi：10.1186/1758-5996-5-5
更新日期：2013-02-06 00:00:00
abstract：BACKGROUND:Evidences support the benefits of moderate- to high-intensity statins for patients with acute myocardial infarction (AMI) except for those with type 2 diabetes mellitus (T2DM) on dialysis after AMI. This study was aimed to investigate the safety and efficacy of secondary prevention of cardiovascular diseases...
journal_title：Diabetology & metabolic syndrome
pub_type： 杂志文章
doi：10.1186/s13098-017-0272-7
更新日期：2017-09-19 00:00:00
abstract：BACKGROUND:Reduced insulin sensitivity not only contributes to the pathogenesis of type 2 diabetes but is also linked to multiple metabolic risk factors and cardiovascular diseases (CVD). A prolonged heart rate-corrected QT interval (QTc interval) is related to ventricular arrhythmias and CVD mortality and exhibits a h...
journal_title：Diabetology & metabolic syndrome
pub_type： 杂志文章
doi：10.1186/s13098-017-0268-3
更新日期：2017-09-11 00:00:00
abstract：BACKGROUND:The vascular complications of outpatients with diabetes at ordinary hospitals vary. Ischemic heart disease is barely predictable after treatment using previously reported therapeutic indices. We developed a simple and noninvasive screening method to evaluate the possibility of ischemic heart disease in patie...
journal_title：Diabetology & metabolic syndrome
pub_type： 杂志文章
doi：10.1186/1758-5996-6-51
更新日期：2014-04-08 00:00:00
abstract：Background:Population attributable fractions (PAFs) are frequently used to quantify the proportion of Type 2 diabetes cases due to single risk factors, an approach which may result in an overestimation of their individual contributions. This study aimed to examine Type 2 diabetes incidence associated with multiple risk...
journal_title：Diabetology & metabolic syndrome
pub_type： 杂志文章
doi：10.1186/s13098-018-0387-5
更新日期：2018-11-22 00:00:00
abstract：BACKGROUND:Many self-management programs have been developed so far. Their effectiveness varies. The program 'Beyond Good Intentions' (BGI) is based on proactive coping and has proven to be (cost-) effective in achieving reductions in BMI and blood pressure in screen-detected type 2 diabetes patients up until nine mont...
journal_title：Diabetology & metabolic syndrome
pub_type： 杂志文章
doi：10.1186/s13098-016-0199-4
更新日期：2016-12-20 00:00:00
abstract：BACKGROUND:Vildagliptin, a DPP-4 inhibitor widely used for the treatment of type 2 diabetes mellitus (T2DM), shows beneficial effects on endothelial function. This study aims to evaluate the effect of vildagliptin on endothelial function and arterial stiffness in patients with T2DM and hypertension. METHODS:Fifty over...
journal_title：Diabetology & metabolic syndrome
pub_type： 杂志文章
doi：10.1186/s13098-015-0062-z
更新日期：2015-08-26 00:00:00
abstract：BACKGROUND:Type 1 diabetes mellitus in pregnant women is associated with an increased risk of congenital malformations, obstetric complications, neonatal morbidity, and mortality. Our aim was to evaluate which factors from the first trimester of pregnancy have a significant impact on the pregnancy outcomes of women wit...
journal_title：Diabetology & metabolic syndrome
pub_type： 杂志文章
doi：10.1186/1758-5996-6-125
更新日期：2014-11-22 00:00:00
